Results 131 to 140 of about 316,033 (212)

Sex-related differences in treatment outcomes of chronic hepatitis C with direct-acting antivirals. [PDF]

World J Hepatol
Feyissa GD.
europepmc   +1 more source

Risk of drug-induced liver injury in chronic hepatitis C and tuberculosis co- infection: a systematic review and meta- analysis. [PDF]

BMC Infect Dis
Wei X, Cai R, Wu X, Su Y, Lian S, Nan T, Ye X, Wei J.   +7 more
europepmc   +1 more source

Real-world Effectiveness and Safety of Coblopasvir plus Sofosbuvir in the Treatment of Chronic Hepatitis C Infection in Wenzhou, Eastern China: A Multicenter Observational Study. [PDF]

J Clin Transl Hepatol
Ruan LM, Zhang XC, Zhang XY, Zhou QQ, Zheng QN, Fu CL, Hu YB, Zhou Y, Wu YH.   +8 more
europepmc   +1 more source

Fibrotic, metabolic and clinical improvements in patients with chronic hepatitis C treated with direct-acting antiviral therapy in a resource limited setting: a prospective cohort study. [PDF]

BMC Gastroenterol
Ekubazgi KW, Dellil M, Woldegeorgis BZ, Berhane KA, Anagaw S, Fisseha H.   +5 more
europepmc   +1 more source

The effect of HFE gene mutation and iron overload on sustained virological response in Egyptian chronic hepatitis C patients treated with daclatasvir and sofosbuvir. [PDF]

Korean J Intern Med
Kodsi EM, Ismail H, Issa R, Elshaarawy A, Sakr MA, Shehata EL, Issak ER.   +6 more
europepmc   +1 more source

Aspartate aminotransferase-to-platelet ratio index (APRI) for staging of fibrosis in adults with chronic hepatitis C. [PDF]

Cochrane Database Syst Rev
Dreytser E, Blyuss O, Mudrova A, Turankova T, Gurusamy KS, Pavlov CS.   +5 more
europepmc   +1 more source

Epidemiological characteristics, genotype patterns, and treatment outcomes in chronic hepatitis C patients receiving direct-acting antivirals: a cohort study from Istanbul, Türkiye. [PDF]

BMC Infect Dis
Karaman Kamalı S, Senoglu S, Kamalı S, Ozdemir YE, Kart Yasar K.   +4 more
europepmc   +1 more source

Injecting Drug Use History and Younger Age Worsen Adherence to Scheduled Hospital Visits in Glecaprevir and Pibrentasvir Therapy for Chronic Hepatitis C. [PDF]

Int J Hepatol
Tawara S, Watanabe A, Yamaguchi J, Omi M, Miyazaki T, Taguchi H, Kiyota R, Yamai T, Kawai S, Inoue T, Yakushijin T.   +10 more
europepmc   +1 more source

Comparison of Noninvasive Methods for the Evaluation of Liver Fibrosis in Children With Chronic Hepatitis C Virus Infection. [PDF]

Pediatr Infect Dis J
Pokorska-Śpiewak M, Dobrzeniecka A, Talarek E, Aniszewska M, Marczyńska M.   +4 more
europepmc   +1 more source